Patent details

Basic Information

Publication number:

EP2988739

PCT Application Number:

EP2014058608

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147201263

PCT Publication Number:

WO2014174119

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUSTAINED RELEASE GUANFACINE HCL CONTAINING FORMULATION

French Title of Invention:

FORMULATION CONTENANT HYDROCHLORIDE DE GUANFACINE À LIBÉRATION PROLONGÉE

German Title of Invention:

GUANFACIN-HCL ENTHALTENDE FORMULIERUNG MIT VERZÖGERTER FREISETZUNG

SPC Number:

Dates

Filing date:

28/04/2014

Grant date:

01/08/2018

EP Publication Date:

02/03/2016

PCT Publication Date:

30/10/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/08/2018

EP B1 Publication Date:

01/08/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/04/2019

Expiration date:

28/04/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/07/2018

 

 

Name:

Salmon Pharma GmbH

Address:

St. Jakobs-Str. 90, 4002 Basel, Switzerland (CH)

Inventor

1

Name:

BAUMSTUEMMLER, Bernd

Address:

Germany (DE)

2

Name:

AMMER, Richard

Address:

Germany (DE)

3

Name:

TUERELI, Akif Emre

Address:

Germany (DE)

Priority

Priority Number:

13165512

Priority Date:

26/04/2013

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/16; A61K 9/20; A61K 31/165; A61K 31/185;

Publication

European Patent Bulletin

Issue number:

201831

Publication date:

01/08/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages